Furthermore, it was widely demonstrated that MM EVs carry specific malignancy markers on their surface, such as CD38 antigen, and that these CD38+MVs were significantly more abundant in BM plasma from 27 MM patients at diagnosis compared to 11 MGUS and 14 SMM patients [46]. The gene discussed is CD38; the disease is Miyoshi myopathy.